Clement J Huysentruyt
Clement J Huysentruyt has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Albert J. H. Suurmeijer
Department of Pathology University Medical Center Groningen, University of Groningen Groningen The Netherlands
1 shared publication - Anya N Milne
Department of Pathology, Diakonessenhuis Utrecht, Utrecht, the Netherlands
1 shared publication - David Creytens
Department of Pathology, Ghent University Hospital, Ghent University, Ghent, Belgium
1 shared publication - Erik. J. Schoon
GROW Research Institute for Oncology and Reproduction, Maastricht University, 6202 AZ Maastricht, The Netherlands
1 shared publication - G. van Lijnschoten
PAMM (laboratory of Pathology and Medical Microbiology), Eindhoven, the Netherlands
1 shared publication - Gabriele Palmedo
Dermatologische Gemeinschaftspraxis
1 shared publication
Latest Publications
- 13 July 2020
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 66 (6) , 1957-1964
Dysplasia in Random Biopsies from Barrett’s Surveillance Is an Important Marker for More Severe Pathology
Background and Aim Although endoscopic recognition of dysplasia in Barrett’s esophagus is difficult, experience in recognition of early neoplastic lesions is supposed to increase the detection of early neoplastic lesions. The aim of this study was to assess the significance of dysplasia in random biopsies in Barrett’s esophagus, in the absence of reported visible lesions as well as the difference in final outcome of pathology. Methods We retrospectively identified all patients with Barrett’s esophagus with suspicion of dysplasia or early adenocarcinoma who were referred to our center between February 2008 and April 2016. We analyzed all endoscopy reports, pathology reports, and referral letters from 19 different hospitals. Patients were divided into two groups, based on the presence or absence of visible lesions reported upon referral. Results In total, 170 patients diagnosed with dysplasia or adenocarcinoma were referred to our tertiary center. Ninety-one of these referred patients were referred with dysplasia or adenocarcinoma in random biopsies, without a reported lesion during endoscopy in the referral center. During endoscopic work-up at our center, a visible lesion was detected in 44 of these 91 patients (48.4%). After endoscopic work-up and treatment, adenocarcinoma was found in an additional 21 patients. Two of these patients were initially referred with low-grade dysplasia, and 19 patients were initially referred with high-grade dysplasia. The final pathology was upstaged in 35.8% of the patients. Conclusions The presence of any grade of dysplasia in random biopsies during surveillance in referral centers is a marker for more severe final pathology. Training in recognition of early neoplastic lesions in Barrett’s esophagus imaging is recommended for endoscopists performing Barrett’s surveillance.
- 13 July 2020
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 66 (6) , 1957-1964
Dysplasia in Random Biopsies from Barrett’s Surveillance Is an Important Marker for More Severe Pathology
Background and Aim Although endoscopic recognition of dysplasia in Barrett’s esophagus is difficult, experience in recognition of early neoplastic lesions is supposed to increase the detection of early neoplastic lesions. The aim of this study was to assess the significance of dysplasia in random biopsies in Barrett’s esophagus, in the absence of reported visible lesions as well as the difference in final outcome of pathology. Methods We retrospectively identified all patients with Barrett’s esophagus with suspicion of dysplasia or early adenocarcinoma who were referred to our center between February 2008 and April 2016. We analyzed all endoscopy reports, pathology reports, and referral letters from 19 different hospitals. Patients were divided into two groups, based on the presence or absence of visible lesions reported upon referral. Results In total, 170 patients diagnosed with dysplasia or adenocarcinoma were referred to our tertiary center. Ninety-one of these referred patients were referred with dysplasia or adenocarcinoma in random biopsies, without a reported lesion during endoscopy in the referral center. During endoscopic work-up at our center, a visible lesion was detected in 44 of these 91 patients (48.4%). After endoscopic work-up and treatment, adenocarcinoma was found in an additional 21 patients. Two of these patients were initially referred with low-grade dysplasia, and 19 patients were initially referred with high-grade dysplasia. The final pathology was upstaged in 35.8% of the patients. Conclusions The presence of any grade of dysplasia in random biopsies during surveillance in referral centers is a marker for more severe final pathology. Training in recognition of early neoplastic lesions in Barrett’s esophagus imaging is recommended for endoscopists performing Barrett’s surveillance.
- Top Cited PapersOpen Access
- 1 July 2014
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 131
Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases
Epithelioid hemangioendothelioma is a malignant, often indolent vascular tumor which occurs at various anatomic sites. Based on a reciprocal translocation t (1;3)(p36;q25), a consistent WWTR1-CAMTA1 fusion gene has been found. An alternate YAP1-TFE3 fusion has been detected in a small and distinct subset of cases.
- 1 July 2014
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 131
Top Cited PapersOpen AccessEpithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases
Epithelioid hemangioendothelioma is a malignant, often indolent vascular tumor which occurs at various anatomic sites. Based on a reciprocal translocation t (1;3)(p36;q25), a consistent WWTR1-CAMTA1 fusion gene has been found. An alternate YAP1-TFE3 fusion has been detected in a small and distinct subset of cases.